Breast
A191901
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy
AFT-25
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
EA1181
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy
EAZ171
Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer
MA.39
Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer (TAILOR RT)
NRG-BR007
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
URCC 16070
Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
URCC 18007
Bupropion in Reducing Cancer Related Fatigue in Stage I-III Breast Cancer Survivors
